USA Today noted that while employers often cover the cost of diabetes medications such as Ozempic and Lillys Mounjaro for their workers, employers are less likely to pick up the tab for weight-loss medications. KFF, quoted in the USA Today article, said 43% of larger employers paid for anti-obesity drugs last year
CNBC , Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices (Nov 2025) ( [17] )
Side Effects of AOD 9604 Because AOD9604 is approved by the FDA, you dont have to worry about experiencing many adverse effects
Its one less thing to worry about during the day, and I can rest easy knowing that the medication is working while I sleep
The medications part of a class of drugs called GLP-1, or glucagon-like peptide-1, receptor agonists were first used to treat diabetes but have since been approved for obesity, which has dramatically expanded the patient pool
Myocardial remodeling has a critical role in heart failure following MI